The tissue factor pathway mediates both activation of coagulation and coagulopathy after injury

Journal of Trauma and Acute Care Surgery

Volumn 79, Issue 6, 2015, Pages 1009-1013

  Howard, Benjamin M ^a   Miyazawa, Byron Y ^a   Dong, Weifeng ^a   Cedron, Wendy J ^a   Vilardi, Ryan F ^a   Ruf, Wolfram ^b   Cohen, Mitchell Jay ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

activated protein C (aPC); coagulation; coagulopathy; mice; Tissue factor

Indexed keywords

ACTIVATED PROTEIN C; HIRUDIN; IMMUNOGLOBULIN G ANTIBODY; RECOMBINANT HIRUDIN; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN; HIRUDIN DERIVATIVE; PROTEIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; BLOOD VESSEL CATHETERIZATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMORRHAGIC SHOCK; LAPAROTOMY; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRAUMATIC SHOCK; ANIMAL; BLOOD; BLOOD COAGULATION DISORDERS; C57BL MOUSE; COMPLICATION; INJURY; METABOLISM;

ANIMALS; BLOOD COAGULATION DISORDERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIRUDINS; MALE; MICE; MICE, INBRED C57BL; PROTEIN C; SHOCK, HEMORRHAGIC; SHOCK, TRAUMATIC; THROMBIN; THROMBOPLASTIN; WOUNDS AND INJURIES;

EID: 84948975704     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000000707     Document Type: Article

References (33)

1. Norton R, Kobusingye O,. Injuries. N Engl J Med. 2013; 368 (18): 1723-1730.
2. Kauvar DS, Lefering R, Wade CE,. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006; 60 (Suppl 6): S3-S11.
3. Hess JR, Holcomb JB, Hoyt DB,. Damage control resuscitation: the need for specific blood products to treat the coagulopathy of trauma. Transfusion. 2006; 46 (5): 685-686.
4. Holcomb JB, Jenkins D, Rhee P, Johannigman J, Mahoney P, Mehta S, Cox ED, Gehrke MJ, Beilman GJ, Schreiber M, Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma. 2007; 62 (2): 307-310.
5. Brohi K, Singh J, Heron M, Coats T,. Acute traumatic coagulopathy. J Trauma. 2003; 54 (6): 1127-1130.
6. MacLeod JB, Lynn M, McKenney MG, Cohn SM, Murtha M,. Early coagulopathy predicts mortality in trauma. J Trauma. 2003; 55 (1): 39-44.
7. Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet JF,. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg. 2007; 245 (5): 812-818.
8. Brohi K, Cohen MJ, Ganter MT, Schultz MJ, Levi M, Mackersie RC, Pittet JF,. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma. 2008; 64 (5): 1211-1217.
9. Brohi K, Cohen MJ, Davenport RA,. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care. 2007; 13 (6): 680-685.
10. Cohen MJ, Call M, Nelson M, Calfee CS, Esmon CT, Brohi K, Pittet JF,. Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients. Ann Surg. 2012; 255 (2): 379-385.
11. Esmon CT,. The protein C pathway. Chest. 2003; 124 (Suppl 3): 26S-32S.
12. Stavenuiter F, Bouwens EA, Mosnier LO,. Down-regulation of the clotting cascade by the protein C pathway. Hematol Educ. 2013; 7 (1): 365-374.
13. Bajzar L, Manuel R, Nesheim ME,. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J Biol Chem. 1995; 270 (24): 14477-14484.
14. Rezaie AR,. Vitronectin functions as a cofactor for rapid inhibition of activated protein C by plasminogen activator inhibitor-1. Implications for the mechanism of profibrinolytic action of activated protein C. J Biol Chem. 2001; 276 (19): 15567-15570.
15. Chesebro BB, Rahn P, Carles M, Esmon CT, Xu J, Brohi K, Frith D, Pittet JF, Cohen MJ,. Increase in activated protein C mediates acute traumatic coagulopathy in mice. Shock. 2009; 32 (6): 659-665.
16. Mackman N, Tilley RE, Key NS,. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol. 2007; 27 (8): 1687-1693.
17. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ,. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010; 464 (7285): 104-107.
18. Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, Taylor FB, Esmon NL, Lupu F, Esmon CT,. Extracellular histones are major mediators of death in sepsis. Nat Med. 2009; 15 (11): 1318-1321.
19. Gould TJ, Vu TT, Swystun LL, Dwivedi DJ, Mai SH, Weitz JI, Liaw PC,. Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms. Arterioscler Thromb Vasc Biol. 2014; 34 (9): 1977-1984.
20. Aberg M, Siegbahn A,. Tissue factor non-coagulant signaling-molecular mechanisms and biological consequences with a focus on cell migration and apoptosis. J Thromb Haemost. 2013; 11 (5): 817-825.
21. Mosnier LO, Zlokovic BV, Griffin JH,. The cytoprotective protein C pathway. Blood. 2007; 109 (8): 3161-3172.
22. Furlan-Freguia C, Marchese P, Gruber A, Ruggeri ZM, Ruf W,. P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice. J Clin Invest. 2011; 121 (7): 2932-2944.
23. Acosta JA, Yang JC, Winchell RJ, Simons RK, Fortlage DA, Hollingsworth-Fridlund P, Hoyt DB,. Lethal injuries and time to death in a level I trauma center. J Am Coll Surg. 1998; 186 (5): 528-533.
24. Johansson PI, Ostrowski SR, Secher NH,. Management of major blood loss: an update. Acta Anaesthesiol Scand. 2010; 54 (9): 1039-1049.
25. Cohen MJ,. Towards hemostatic resuscitation: the changing understanding of acute traumatic biology, massive bleeding, and damage-control resuscitation. Surg Clin North Am. 2012; 92 (4): 877-891,. viii.
26. Cohen MJ, Kutcher M, Redick B, Nelson M, Call M, Knudson MM, Schreiber MA, Bulger EM, Muskat P, Alarcon LH, Clinical and mechanistic drivers of acute traumatic coagulopathy. J Trauma Acute Care Surg. 2013; 75 (1 Suppl 1): S40-S47.
27. Pawlinski R, Pedersen B, Erlich J, Mackman N,. Role of tissue factor in haemostasis, thrombosis, angiogenesis and inflammation: lessons from low tissue factor mice. Thromb Haemost. 2004; 92 (3): 444-450.
28. Lo YM, Rainer TH, Chan LY, Hjelm NM, Cocks RA,. Plasma DNA as a prognostic marker in trauma patients. Clin Chem. 2000; 46 (3): 319-323.
29. Swystun LL, Mukherjee S, Liaw PC,. Breast cancer chemotherapy induces the release of cell-free DNA, a novel procoagulant stimulus. J Thromb Haemost. 2011; 9 (11): 2313-2321.
30. Bae JS, Yang L, Manithody C, Rezaie AR,. Engineering a disulfide bond to stabilize the calcium-binding loop of activated protein C eliminates its anticoagulant but not its protective signaling properties. J Biol Chem. 2007; 282 (12): 9251-9259.
31. Maegele M, Schochl H, Cohen MJ,. An update on the coagulopathy of trauma. Shock. 2014; 41 (Suppl 1): 21-25.
32. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I,. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 1999; 8 (4): 265-277.
33. Pawlinski R, Wang JG, Owens AP 3rd, Williams J, Antoniak S, Tencati M, Luther T, Rowley JW, Low EN, Weyrich AS, Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice. Blood. 2010; 116 (5): 806-814.